References
GeM-HD Consortium (2015) Identification of genetic factors that modify clinical onset of Huntington’s disease. Cell 162(3):516–526
Kota LN, Bharath S, Purushottam M et al (2015) Reduced telomere length in neurodegenerative disorders may suggest shared biology. J Neuropsychiatry Clin Neurosci 27(2):e92–e96
Zhan Y, Song C, Karlsson R et al (2015) Telomere length shortening and Alzheimer disease—a Mendelian randomization study. JAMA Neurol 72(10):1202–1203
Davey Smith G, Hemani G (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23(R1):R89–R98
Codd V, Nelson CP, Albrecht E et al (2013) Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 45(4):422–427
Hemani G, Zheng J, Wade KH et al (2016) MR-base: a platform for systematic causal inference across the phenome using billions of genetic associations. bioRxiv. https://doi.org/10.1101/078972
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr Aziz and Dr Weydt report no conflicts of interest.
Rights and permissions
About this article
Cite this article
Aziz, N.A., Weydt, P. Telomere length as a modifier of age-at-onset in Huntington disease: a two-sample Mendelian randomization study. J Neurol 265, 2149–2151 (2018). https://doi.org/10.1007/s00415-018-8972-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-018-8972-y